Global Prostate Cancer Testing Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI12249332

Publication Date:

December 13, 2024

Pages:

100

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Prostate Cancer Testing market size was valued at US$ 13140 million in 2023. With growing demand in downstream market, the Prostate Cancer Testing is forecast to a readjusted size of US$ 22410 million by 2030 with a CAGR of 7.9% during review period.
The research report highlights the growth potential of the global Prostate Cancer Testing market. Prostate Cancer Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Prostate Cancer Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Prostate Cancer Testing market.
Prostate cancer testing refers to the tests conducted for the detection, localization, grading, and staging of prostate carcinoma. The currently established methods of prostate cancer detection include digital rectal examination (DRE), serum prostate-specific antigen (PSA) tests, and transrectal ultrasound (TRUS)-guided prostate biopsy using a systematic 12-core method.
The high prevalence rate of prostate cancer is a key factor, which is driving the global market for the prostate cancer. Prostate cancer is the second-leading cause of death in the United States. According to National Cancer Institute, it is estimated that there were around 161,360 new cases of prostate cancer and an estimated 26,730 people will die due to it. Based on these statistics, we can see that the prevalence rate of prostate cancer is increasing across the world and hence, it is driving the market.
Key Features:
The report on Prostate Cancer Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Prostate Cancer Testing market. It may include historical data, market segmentation by Type (e.g., PSA Tests, CTC Tests), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Prostate Cancer Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Prostate Cancer Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Prostate Cancer Testing industry. This include advancements in Prostate Cancer Testing technology, Prostate Cancer Testing new entrants, Prostate Cancer Testing new investment, and other innovations that are shaping the future of Prostate Cancer Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Prostate Cancer Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Prostate Cancer Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Prostate Cancer Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Prostate Cancer Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Prostate Cancer Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Prostate Cancer Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Prostate Cancer Testing market.
Market Segmentation:
Prostate Cancer Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
PSA Tests
CTC Tests
Immunohistochemistry
PCA3 Tests
Others
Segmentation by application
Hospital Associated Labs
Independent Diagnostic Laboratories
Cancer Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Genomic Health
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prostate Cancer Testing Market Size 2019-2030
2.1.2 Prostate Cancer Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Prostate Cancer Testing Segment by Type
2.2.1 PSA Tests
2.2.2 CTC Tests
2.2.3 Immunohistochemistry
2.2.4 PCA3 Tests
2.2.5 Others
2.3 Prostate Cancer Testing Market Size by Type
2.3.1 Prostate Cancer Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Prostate Cancer Testing Market Size Market Share by Type (2019-2024)
2.4 Prostate Cancer Testing Segment by Application
2.4.1 Hospital Associated Labs
2.4.2 Independent Diagnostic Laboratories
2.4.3 Cancer Research Institutes
2.4.4 Others
2.5 Prostate Cancer Testing Market Size by Application
2.5.1 Prostate Cancer Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Prostate Cancer Testing Market Size Market Share by Application (2019-2024)
3 Prostate Cancer Testing Market Size by Player
3.1 Prostate Cancer Testing Market Size Market Share by Players
3.1.1 Global Prostate Cancer Testing Revenue by Players (2019-2024)
3.1.2 Global Prostate Cancer Testing Revenue Market Share by Players (2019-2024)
3.2 Global Prostate Cancer Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Prostate Cancer Testing by Regions
4.1 Prostate Cancer Testing Market Size by Regions (2019-2024)
4.2 Americas Prostate Cancer Testing Market Size Growth (2019-2024)
4.3 APAC Prostate Cancer Testing Market Size Growth (2019-2024)
4.4 Europe Prostate Cancer Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Prostate Cancer Testing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Prostate Cancer Testing Market Size by Country (2019-2024)
5.2 Americas Prostate Cancer Testing Market Size by Type (2019-2024)
5.3 Americas Prostate Cancer Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostate Cancer Testing Market Size by Region (2019-2024)
6.2 APAC Prostate Cancer Testing Market Size by Type (2019-2024)
6.3 APAC Prostate Cancer Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Prostate Cancer Testing by Country (2019-2024)
7.2 Europe Prostate Cancer Testing Market Size by Type (2019-2024)
7.3 Europe Prostate Cancer Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prostate Cancer Testing by Region (2019-2024)
8.2 Middle East & Africa Prostate Cancer Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Prostate Cancer Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Prostate Cancer Testing Market Forecast
10.1 Global Prostate Cancer Testing Forecast by Regions (2025-2030)
10.1.1 Global Prostate Cancer Testing Forecast by Regions (2025-2030)
10.1.2 Americas Prostate Cancer Testing Forecast
10.1.3 APAC Prostate Cancer Testing Forecast
10.1.4 Europe Prostate Cancer Testing Forecast
10.1.5 Middle East & Africa Prostate Cancer Testing Forecast
10.2 Americas Prostate Cancer Testing Forecast by Country (2025-2030)
10.2.1 United States Prostate Cancer Testing Market Forecast
10.2.2 Canada Prostate Cancer Testing Market Forecast
10.2.3 Mexico Prostate Cancer Testing Market Forecast
10.2.4 Brazil Prostate Cancer Testing Market Forecast
10.3 APAC Prostate Cancer Testing Forecast by Region (2025-2030)
10.3.1 China Prostate Cancer Testing Market Forecast
10.3.2 Japan Prostate Cancer Testing Market Forecast
10.3.3 Korea Prostate Cancer Testing Market Forecast
10.3.4 Southeast Asia Prostate Cancer Testing Market Forecast
10.3.5 India Prostate Cancer Testing Market Forecast
10.3.6 Australia Prostate Cancer Testing Market Forecast
10.4 Europe Prostate Cancer Testing Forecast by Country (2025-2030)
10.4.1 Germany Prostate Cancer Testing Market Forecast
10.4.2 France Prostate Cancer Testing Market Forecast
10.4.3 UK Prostate Cancer Testing Market Forecast
10.4.4 Italy Prostate Cancer Testing Market Forecast
10.4.5 Russia Prostate Cancer Testing Market Forecast
10.5 Middle East & Africa Prostate Cancer Testing Forecast by Region (2025-2030)
10.5.1 Egypt Prostate Cancer Testing Market Forecast
10.5.2 South Africa Prostate Cancer Testing Market Forecast
10.5.3 Israel Prostate Cancer Testing Market Forecast
10.5.4 Turkey Prostate Cancer Testing Market Forecast
10.5.5 GCC Countries Prostate Cancer Testing Market Forecast
10.6 Global Prostate Cancer Testing Forecast by Type (2025-2030)
10.7 Global Prostate Cancer Testing Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Genomic Health
11.1.1 Genomic Health Company Information
11.1.2 Genomic Health Prostate Cancer Testing Product Offered
11.1.3 Genomic Health Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Genomic Health Main Business Overview
11.1.5 Genomic Health Latest Developments
11.2 OPKO
11.2.1 OPKO Company Information
11.2.2 OPKO Prostate Cancer Testing Product Offered
11.2.3 OPKO Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 OPKO Main Business Overview
11.2.5 OPKO Latest Developments
11.3 Siemens Healthcare
11.3.1 Siemens Healthcare Company Information
11.3.2 Siemens Healthcare Prostate Cancer Testing Product Offered
11.3.3 Siemens Healthcare Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Siemens Healthcare Main Business Overview
11.3.5 Siemens Healthcare Latest Developments
11.4 DiaSorin
11.4.1 DiaSorin Company Information
11.4.2 DiaSorin Prostate Cancer Testing Product Offered
11.4.3 DiaSorin Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 DiaSorin Main Business Overview
11.4.5 DiaSorin Latest Developments
11.5 bioMeriux
11.5.1 bioMeriux Company Information
11.5.2 bioMeriux Prostate Cancer Testing Product Offered
11.5.3 bioMeriux Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 bioMeriux Main Business Overview
11.5.5 bioMeriux Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Prostate Cancer Testing Product Offered
11.6.3 Roche Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 MDx Health
11.7.1 MDx Health Company Information
11.7.2 MDx Health Prostate Cancer Testing Product Offered
11.7.3 MDx Health Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 MDx Health Main Business Overview
11.7.5 MDx Health Latest Developments
11.8 Beckman Coulter
11.8.1 Beckman Coulter Company Information
11.8.2 Beckman Coulter Prostate Cancer Testing Product Offered
11.8.3 Beckman Coulter Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Beckman Coulter Main Business Overview
11.8.5 Beckman Coulter Latest Developments
11.9 Myriad Genetics
11.9.1 Myriad Genetics Company Information
11.9.2 Myriad Genetics Prostate Cancer Testing Product Offered
11.9.3 Myriad Genetics Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Myriad Genetics Main Business Overview
11.9.5 Myriad Genetics Latest Developments
11.10 Ambry Genetics
11.10.1 Ambry Genetics Company Information
11.10.2 Ambry Genetics Prostate Cancer Testing Product Offered
11.10.3 Ambry Genetics Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Ambry Genetics Main Business Overview
11.10.5 Ambry Genetics Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂